This double blind clinical study was designed to examine the clinical effects of an aluminum chloride and zinc sulfate solution on dentin hypersensitivity.The results were as follows: From the above results, the solution can be regarded as effective against dentin hypersensitivity.
Doga r proteinase inhibitor (a r PI) was found to be an effective inhibitor of bovine chymotrypsin and also of porcine pancreatic elastase as in the case of human inhibitor. The dog inhibitor inactivated both proteinases at a molar ratio of 1:1. However, compared to the human inhibitor, dog c^ -PI was a relatively poor inhibitor of bovine trypsin. The association rate constants (k^) of the interactions of dog a,-PI with bovine chymotrypsin and with porcine elastase were determined to be 6.9 ± 0.3 χ lO^-V 1 and 6.4 ±0.1 χ l O 5 M" 1 s" 1 , respectively. These values are 1.3-and 2.7-fold higher than the corresponding values for the human inhibitor. On the other hand, k^ for the dog inhibitor with bovine trypsin (2.6 ± 0.3 χ ΙΟ 4 !^' 1 s" 1 ) was found to be about 5 times smaller than that of the human inhibitor.
Vergleich der Hemmeigenschaften der otj-ProteinaseZusammenfassung: Der a r Proteinase-Inhibitor (o^-PI) des Hundes erwies sich, ebenso wie der menschliche Inhibitor, als wirkungsvoller Hemmer sowohl des Rinder-Chymotrypsins als auch der Pankreas-Elastase des Schweines. Der Inhibitor des Hundes inaktivierte beide Proteinasen mit einer St chiometrie von 1:1. Gegen ber Rinder-Trypsin dagegen war a r PI vom Hund im Vergleich zum menschlichen Inhibitor ein relativ schwacher Hemmstoff. Die Assoziationskonstan-
-Inhibitoren von Hund und Mensch
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.